ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "NETWise Episode 19: NET Research—Part One"
Episode Synopsis
Episode 19 is the first of two episodes that will discuss a topic near and dear to us here at NETRF: NET research. Advancing NET research is the core of our mission, and it’s a crucial need, because NETs are extremely complicated cancers and there is still a lot the medical community needs to learn about them.
How do scientists do research, from beginning to end? And what are some of the challenges that specifically face NET researchers as they work through that process? Learn why basic research in the laboratory is crucial to discovering new treatments. Clinical trials are just the last stage of this process, and they cannot happen without years of careful pre-clinical work, which is often underappreciated and underfunded.After you’ve listened to the episode, test your NET Knowledge by taking the LACNETS quiz here.
NET experts featured in this episode:Use our episode infographics to get a visual picture of some of the things we have discussed.
John Kanki, PhDDirector of ResearchNETRF
Dawn Quelle, PhD Professor of Pharmacology and NeurologyHolden Comprehensive Cancer Center University of Iowa, College of MedicineCo-Chair of NETRF Board of Scientific Advisors
Ramesh Shivdasani, MD, PhD Oncologist,Dana-Farber Cancer InstituteProfessor,Harvard Medical SchoolNETRF Board of Scientific Advisors
Chrissie Thirlwell, MD, PhDMireille Gillings Professor of Cancer GenomicsUniversity of Exeter Co-Chair of NETRF Board of Scientific Advisors
After you listen to the episode, test your knowledge by taking the LACNETS quiz here
Download episode transcript here
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer GuideInformation and Resources for the Newly DiagnosedNETRF YouTube Channel
LISTEN TO OUR NETWISE PODCASTNETWise Episode 31: 2023 Year in Review
GET INSIGHTS FROM THE EXPERTSNETRF 2023 Research Symposium: Personalized Medicine NETRF 2023 Research Symposium: Improving Radiotheranostics NETRF 2023 Research Symposium: NET Pathways & Targets NETRF 2023 Research Symposium: Tumor Evolution & Microenvironment NETRF 2024 Know Your NETs Virtual Conference: Combining & Sequencing Novel NETRF 2024 Providence Conference: Basic and Translational Research NETRF 2024 Providence Conference: NET Clinical Trials NETRF 2024 Know Your NETs Virtual Conference: Welcome & Discovery in NETs w/ Basic
EXPLORE NETRF-SUPPORTED RESEARCH Celebrating Milestones in Neuroendocrine Tumor Research (2023) NETRF Awards Eleven Research Grants to Study Neuroendocrine Cancer NETRF Research Highlights 2023: Drug-tolerant persister cells in relapsed high-grade neuroendocrine carcinoma, by Carl Gay, MD, PhD NETRF Research Highlights 2023: NET-SMART therapy, a targeted prodrug strategy, by Justin Annes, MD, PhD NETRF Research Highlights 2023: Imaging and endo radiotherapy of NETs by endocytic modulation of somatostatin receptors, by Patricia Pereira, PhD NETRF Research Highlights 2023: Targeting serotonin metabolism in small bowel NETs, by Po Hien Ear, PhD NETRF Research Highlights 2023: Novel PDXovo models for neuroendocrine neoplasms, by Iacovos Michael, PhDAdvancing Neuroendocrine Tumor Research Through a New Clinically Relevant Mouse Model
The post NETWise Episode 19: NET Research—Part One appeared first on NETRF.
In God we trust